News | Molecular Imaging | March 28, 2023

A new article in The Journal of Nuclear Medicine explores the potential for using ChatGPT, an artificial intelligence chatbot, in the field of nuclear medicine and molecular imaging

A new article in The Journal of Nuclear Medicine explores the potential for using ChatGPT, an artificial intelligence chatbot, in the field of nuclear medicine and molecular imaging

March 28, 2023 — A new article in The Journal of Nuclear Medicine explores the potential for using ChatGPT, an artificial intelligence chatbot, in the field of nuclear medicine and molecular imaging. In the article, Irène Buvat, PhD, and Wolfgang Weber, MD, PhD, report on discussions they held with ChatGPT regarding several nuclear medicine and molecular imaging topics and provide their commentary on the pros and cons of using the chatbot.

Developed by OpenAI, ChatGPT is a natural language processing chatbot that can intelligently respond to questions. In conversations with users, the chatbot always “pays attention” and remembers the thread of the dialogue. It is available in more than 90 languages and can be instructed to adopt a specific style, for example, Shakesperean or journalistic language.

Buvat and Weber challenged ChatGPT with questions relevant to nuclear medicine and molecular imaging to illustrate the role it could play in the field. ChatGPT received no special preparation for the interview and responded entirely with information from its extensive dataset. The responses of ChatGPT illustrate the strengths and weaknesses of current artificial intelligence bots.

According to Buvat and Weber, artificial intelligence bots such as ChatGPT “should not be feared but rather considered promising allies who will help us cope with ever-increasing workloads, freeing up time to devote to patients and colleagues and to expend more energy on tasks that require unique and advanced expertise.”

For more information: www.snmmi.org


Related Content

News | PET Imaging

Jun. 24, 2025 — GE HealthCare has announced that the U.S. Food and Drug Administration (FDA) approved an updated label ...

Time June 24, 2025
arrow
News | PET Imaging

June 19, 2025 – dGenThera, Inc., a biotechnology company pioneering theranostic molecular pairs, and Nusano, a physics ...

Time June 24, 2025
arrow
News | PET-CT

June 23, 2025 — GE HealthCare’s commitment to advancing precision care in cardiology through its molecular imaging ...

Time June 23, 2025
arrow
News | Nuclear Imaging

June 23, 2025 — Serac Imaging Systems Ltd. and its clinical investigators from The Ohio State University Wexner Medical ...

Time June 23, 2025
arrow
News | Nuclear Imaging

May 5, 2025 — GE HealthCare recently announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance ...

Time May 06, 2025
arrow
News | Prostate Cancer

July 30, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...

Time July 30, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 25, 2024 — NorthStar Medical Radioisotopes, LLC and BWXT Medical Ltd., a subsidiary of BWX Technologies, Inc ...

Time July 25, 2024
arrow
News | PET-CT

July 25, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET & PET-CT imaging ...

Time July 25, 2024
arrow
News | Computed Tomography (CT)

July 15, 2024 — NeuroLogica Corp, a subsidiary of Samsung Electronics Co. Ltd., announced its latest configuration of ...

Time July 15, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
Subscribe Now